Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

DOI Full Paper Access

54

Citations

19

References

2024

Year

Hans Gelderblom, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Abdul Razak, Antoîne Italiano,

Surgical OncologyMedicineImmunologyPathologyImmune Checkpoint InhibitorPharmacotherapyVimseltinib Versus PlaceboCancer TreatmentOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1